|
|
Volumn 32, Issue 11, 2001, Pages 1554-1561
|
|
Oropharyngeal candidiasis in patients with human immunodeficiency virus: Correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression
a a a a a
a
NONE
(Canada)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PYRROLE;
ADOLESCENT;
ADULT;
ARTICLE;
CANDIDIASIS;
CHILD;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE DEFICIENCY;
INFECTION RISK;
INFECTION SENSITIVITY;
LYMPHOCYTE COUNT;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTIFUNGAL AGENTS;
CANDIDIASIS;
CHILD;
DRUG RESISTANCE, MICROBIAL;
FEMALE;
FLUCONAZOLE;
HIV-1;
HUMANS;
IMMUNE TOLERANCE;
ITRACONAZOLE;
KETOCONAZOLE;
MALE;
MICROBIAL SENSITIVITY TESTS;
OROPHARYNX;
PHARYNGEAL DISEASES;
|
|
EID: 0035371319
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/320517 Document Type: Article |
|
Times cited : (29)
|
|
References (27)
|